Eczema Linked to Increased Risk of Bone Fracture

This article originally appeared here.
Share this content:
Eczema Linked to Increased Risk of Bone Fracture
Eczema Linked to Increased Risk of Bone Fracture

FRIDAY, Oct. 31, 2014 (HealthDay News) -- Eczema may increase the risk of bone fractures and joint injuries, according to research published online Oct. 29 in JAMA Dermatology.

In a study of 34,500 adults, researchers found that among 7 percent of people who had an eczema flare-up in the past year, 1.5 percent had a bone or joint injury and 0.6 percent had an injury that caused a limitation of function. Compared to people without eczema, those with the skin condition had more than double the risk of having had a fracture or bone or joint injury. The researchers also found that the risk of injuries increased with age and peaked at 50 to 69.

"Adults with eczema have higher rates of injuries, including fractures and bone and joint injuries," lead researcher Jonathan Silverberg, M.D., Ph.D., M.P.H., an assistant professor of dermatology at Northwestern University in Chicago, told HealthDay. Although this study found an association between eczema and bone and joint injuries, it wasn't designed to prove whether eczema is somehow a direct cause of those injuries.

"Eczema by itself was associated with higher rates of injuries. However, adults with eczema who also had sleep disturbance or psychiatric and behavioral disorders had even higher risk of injuries than those with eczema alone," Silverberg said. Adults with eczema have a number of risk factors for injuries, including distraction caused by itch, sleep deprivation, psychological and behavioral disorders, and the use of sleep aids and steroids that may lower bone strength, he said.

Full Article
Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »